GSK

GlaxoSmithKline PLC

Price

$59.18

return (12m)

p/e

13.20

p/bv

4.46

DIVIDEND YIELD

3.41%

GSK price

GlaxoSmithKline

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GSK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals GSK

Valuation

P/E

13.20

Sector -2.34

Industry -6.52

P/BV

4.46

Sector 2.17

Industry 1.78

P/Revenue (PSR)

2.35

Sector 2.00

Industry 3.10

EV/EBITDA

26.75

Sector -23.69

Industry -28.17

EV/EBIT

32.11

Sector -36.60

Industry -41.91

P/EBITDA

7.33

Sector -0.10

Industry -3.02

P/EBIT

9.46

Sector -2.08

Industry -5.99

P/Total Assets

1.24

Sector 1.18

Industry 1.22

P/Net Current Assets

-2.80

Sector -10.91

Industry -7.72

P/Working Capital

-16.63

Sector 0.09

Industry 0.93

EPS

3.90

Sector -0.93

Industry -1.40

BVPS

11.55

Sector 3.87

Industry 1.97

Efficiency

Gross Margin

72.68%

Sector 44.28%

Industry 46.71%

EBITDA Margin

36.36%

Sector -291.45%

Industry -17,446,152.48%

EBIT Margin

30.29%

Sector -195.44%

Industry -17,707,972.85%

Operating Margin

25.68%

Sector -25.72%

Industry -34.74%

Net Profit Margins

17.79%

Sector -30.19%

Industry -38.14%

Asset Turnover

0.12

Sector 0.12

Industry 0.05

Profitability

ROE

33.77%

Sector -34.71%

Industry -50.12%

ROA

9.36%

Sector -28.76%

Industry -54.08%

ROIC

13.87%

Sector -441.27%

Industry -529.87%

Dividends

Dividend yield

3.41%

Sector -

Industry -

Payout

45.01%

Sector -

Industry -

Debt

Current Ratio

0.79

Sector 1.87

Industry 2.30

Net Debt / EBITDA

-1.24

Sector -2.18

Industry 0.95

Net Debt / EBIT

-1.49

Sector -0.74

Industry -0.05

Net Debt / Equity

-0.20

Sector -0.34

Industry -0.49

Gross Debt / Equity

0.00

Sector -0.64

Industry 0.03

Equity/Assets

0.28

Sector 0.43

Industry 0.46

Liabilities/Assets

0.72

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

3.58%

Sector -

Industry -

5Y Earnings CAGR

6.92%

Sector -

Industry -

FAIR VALUE OF GlaxoSmithKline ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$59.18

Fair Value

$31.84

Upside Return potential.

-46.21%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GSK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GSK GlaxoSmithKline PLC	$59.18	77.64%	3.41%	13.20	4.46	33.77%	17.79%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GSK Historical Dividends

current DY: 3.41%

5-year average DY: 5.20%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/20/2026	04/09/2026	0.48560000
Dividends	11/14/2025	01/08/2026	0.40960000
Dividends	08/15/2025	10/09/2025	0.42810000
Dividends	05/16/2025	07/10/2025	0.42910000
Dividends	02/21/2025	04/10/2025	0.40060000
Dividends	11/15/2024	01/09/2025	0.38900000
Dividends	08/16/2024	10/10/2024	0.38570000
Dividends	05/17/2024	07/11/2024	0.37620000
Dividends	02/23/2024	04/11/2024	0.40610000
Dividends	11/17/2023	01/11/2024	0.33980000
Dividends	08/18/2023	10/12/2023	0.36130000
Dividends	05/19/2023	07/13/2023	0.34750000
Dividends	02/24/2023	04/13/2023	0.34040000
Dividends	11/18/2022	01/12/2023	0.31710000
Dividends	08/19/2022	10/06/2022	0.39080000
Dividends	05/20/2022	07/01/2022	0.34960000
Dividends	02/25/2022	04/07/2022	0.62210000
Dividends	11/19/2021	01/13/2022	0.52340000
Dividends	08/20/2021	10/07/2021	0.53010000
Dividends	05/21/2021	07/08/2021	0.52700000
Dividends	02/19/2021	04/08/2021	0.63670000
Dividends	11/13/2020	01/14/2021	0.49600000
Dividends	08/14/2020	10/08/2020	0.49290000
Dividends	05/15/2020	07/09/2020	0.47390000
Dividends	02/21/2020	04/09/2020	0.59900000
Dividends	11/15/2019	01/09/2020	0.48900000
Dividends	08/09/2019	10/10/2019	0.46580000
Dividends	05/17/2019	07/11/2019	0.49530000
Dividends	02/22/2019	04/11/2019	0.60170000
Dividends	11/16/2018	01/10/2019	0.48380000
Dividends	08/10/2018	10/11/2018	0.50110000
Dividends	05/11/2018	07/12/2018	0.53000000
Dividends	02/23/2018	04/12/2018	0.63800000
Dividends	11/10/2017	01/11/2018	0.50400000
Dividends	08/11/2017	10/12/2017	0.50100000
Dividends	05/12/2017	07/13/2017	0.49040000
Dividends	02/24/2017	04/13/2017	0.57120000
Dividends	11/04/2016	01/12/2017	0.46210000
Dividends	08/12/2016	10/13/2016	0.49900000
Dividends	05/13/2016	07/14/2016	0.55400000
Dividends	02/19/2016	04/14/2016	1.25200000
Dividends	11/13/2015	01/14/2016	0.58200000
Dividends	08/14/2015	10/01/2015	0.59300000
Dividends	05/15/2015	07/09/2015	0.57790000
Dividends	02/20/2015	04/09/2015	0.68540000
Dividends	11/07/2014	01/08/2015	0.60440000
Dividends	08/08/2014	10/02/2014	0.63910000
Dividends	05/16/2014	07/10/2014	0.63100000
Dividends	02/21/2014	04/10/2014	0.75000000
Dividends	11/15/2013	01/09/2014	0.60740000
Dividends	08/09/2013	10/03/2013	0.54540000
Dividends	05/10/2013	07/11/2013	0.54250000
Dividends	02/22/2013	04/11/2013	0.67980000
Dividends	11/16/2012	01/03/2013	0.57080000
Dividends	08/10/2012	10/04/2012	0.52050000
Dividends	05/11/2012	07/05/2012	0.54140000
Dividends	02/17/2012	04/12/2012	0.82100000
Dividends	11/04/2011	01/05/2012	0.53350000
Dividends	08/05/2011	10/06/2011	0.51200000
Dividends	05/06/2011	07/07/2011	0.51710000
Dividends	02/11/2011	04/07/2011	0.61500000
Dividends	10/29/2010	01/06/2011	0.49850000
Dividends	07/30/2010	10/07/2010	0.44920000
Dividends	05/07/2010	07/08/2010	0.45230000
Dividends	02/12/2010	04/08/2010	0.57400000
Dividends	11/06/2009	01/07/2010	0.48140000
Dividends	07/31/2009	10/08/2009	0.45290000
Dividends	05/01/2009	07/09/2009	0.40210000
Dividends	02/13/2009	04/09/2009	0.48590000
Dividends	10/31/2008	01/08/2009	0.46650000
Dividends	08/01/2008	10/09/2008	0.51000000
Dividends	05/02/2008	07/10/2008	0.50950000
Dividends	02/15/2008	04/10/2008	0.62700000
Dividends	11/02/2007	01/10/2008	0.52320000
Dividends	08/03/2007	10/11/2007	0.48600000
Dividends	05/04/2007	07/12/2007	0.47220000
Dividends	02/16/2007	04/12/2007	0.55200000
Dividends	11/03/2006	01/04/2007	0.44260000
Dividends	08/04/2006	10/05/2006	0.39920000
Dividends	05/12/2006	07/06/2006	0.38630000
Dividends	02/17/2006	04/06/2006	0.47890000
Dividends	11/04/2005	01/05/2006	0.34900000
Dividends	08/05/2005	10/06/2005	0.34170000
Dividends	05/13/2005	07/07/2005	0.37340000
Dividends	02/18/2005	04/07/2005	0.43660000
Dividends	11/05/2004	01/06/2005	0.35880000
Dividends	08/06/2004	09/30/2004	0.35950000
Dividends	05/14/2004	07/01/2004	0.34660000
Dividends	02/20/2004	04/15/2004	0.51080000
Dividends	10/31/2003	01/06/2004	0.29490000
Dividends	08/01/2003	10/02/2003	0.28130000
Dividends	05/09/2003	07/03/2003	0.31700000
Dividends	02/21/2003	04/17/2003	0.45700000
Dividends	11/01/2002	01/03/2003	0.30260000
Dividends	08/02/2002	10/03/2002	0.30590000
Dividends	05/03/2002	07/05/2002	0.55500000
Dividends	02/22/2002	04/18/2002	0.71500000
Dividends	11/02/2001	01/03/2002	0.27930000
Dividends	08/03/2001	10/04/2001	0.27790000
Dividends	05/04/2001	07/05/2001	0.28230000
Dividends	12/26/2000	04/27/2001	0.74200000
Dividends	08/11/2000	10/26/2000	0.50200000
Dividends	03/03/2000	06/05/2000	0.78500000
Dividends	08/13/1999	10/12/1999	0.53970000
Dividends	03/05/1999	06/01/1999	0.59500000
Dividends	08/14/1998	10/13/1998	0.49980000
Dividends	03/06/1998	06/01/1998	0.65200000
Dividends	08/15/1997	12/02/1997	0.49100000
Dividends	03/21/1997	05/30/1997	0.72700000
Dividends	08/20/1996	10/11/1996	0.58400000
Dividends	03/26/1996	05/30/1996	0.58000000
Dividends	09/26/1995	11/02/1995	0.77400000
Dividends	03/02/1995	04/20/1995	0.38500000

ABOUT GlaxoSmithKline

GlaxoSmithKline PLC

Average Investor10 user rating

4.0 (0 people)

States of America

27 years

Founded: 1999

1987

Time since IPO - 39 years

90.090

Employees

GlaxoSmithKline PLC (States of America) is listed on the NYSE and has a market capitalization of $103.53 billion, with shareholders equity totaling $23.23 billion.

The company employs approximately 90.090 people and operates in the Saúde sector, within the Produtos Farmacêuticos industry.

Over the past 12 months, GlaxoSmithKline PLC reported $44.09 billion in revenue, generating net income of $7.85 billion.

Key financial metrics include a P/E ratio of 13.20, a price-to-book (P/B) ratio of 4.46, and a trailing twelve-month dividend yield of 3.41%.

The company trades under the ticker GSK.

Market cap

$103.53 billion

Net worth

$23.23 billion

$23,229,330,000.00

Assets

$83.83 billion

$83,825,330,000.00

Total Shares Outstanding

2.01 billion

2,012,000,000

Average Daily Trading Volume

$3.77 million

$3,773,278.00

Sector

Saúde

Industry

Produtos Farmacêuticos

GSK

revenue by Business Segment GlaxoSmithKline

GSK revenue and profits

Financial Results GSK

DRAG THE FRAME TO SEE MORE DATA

GSK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56